Advanced-phase studies (Phase 3 and 4) continue to support its core applications in diabetes and obesity, but early research into its use for neurodegenerative and liver-related disorders presents opportunities for future market growth
As previously pointed out, diets containing as low as 0.3 mg/kg of AFB1 could increase apoptosis of thymocytes, induce histopathological lesions of the thymus, and lower the number of mature thymocytes
If you are curious about how these compounds are marketed, you can browse a general peptide products directory, but remember these are not approved for body contouring
The test helps to understand where your metabolism, sugar levels, and heart health stand
For 95% of patients who need treatment in 2026 or 2027, tirzepatide is the right choice not because it's the better drug on efficacy, but because it's the drug that exists right now